WISH Skin Labs is a fusion of modern and ancient healing wisdom from cultures around the planet, united and accessible and with synergy realizing the achievement of health and healing in a global culture of well-being in mind, body, and spirit. Activating transparent practices, sustainable agriculture, organic origins, and expert leadership, WISH Skin Labs is cultivating the transformation of health and healing for the whole body.
Wish Innovations PBC is dedicated to sourcing organically, sustainably grown hemp, extracting and refining its crude oil into a highly purified broad spectrum concentrate using proprietary clean, low-temperature extraction and distillation processes with 10%yields of biomass.
This blend of whole plant phytochemicals (terpenes, flavonoids and cannabinoids) will be packaged inside a our proprietary entourage blend, CUTANACAE™, creating the principal active, biosimilar component of our many product embodiments.
Research regarding the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabis or isolated cannabinoids (such as cannabidiol, commonly referred to as CBD and tetrahydrocannabinol, commonly referred to as THC) remains in the early stages. There have been relatively few US-based clinical trials on the benefits of hemp-derived isolated cannabinoids (such as hCBD, hCBG or hCBC). Although we believe that various articles, reports and studies support our beliefs regarding the medical benefits, viability, safety, efficacy, dosing and social acceptance of cannabinoids, future research and clinical trials may prove such statements to be incorrect or could raise concerns regarding, and perceptions relating to, cannabinoids. Further, the federal illegality of cannabis and associated limits on our ability to properly fund and conduct research on cannabis and cannabis derivatives and the paucity of formal Food and Drug Administration oversight of cannabis and cannabis derivatives, there is limited information about the long-term safety and efficacy of cannabinoids in their various forms, when combusted or combined with various cannabinoids and/or non-cannabis derived ingredients and materials or when ingested, inhaled or topically applied. Future research or oversight may reveal negative health and safety effects, which may significantly impact our reputation, operations and financial performance.
Given these risks, uncertainties and assumptions, prospective purchasers of Subordinate Voting Shares should not place undue reliance on such articles and reports. Future research studies and clinical trials may draw opposing conclusions to those stated in our solicitations or reach negative conclusions regarding the medical benefits, viability, safety, efficacy, dosing, social acceptance or other facts and perceptions related to cannabinoids, which could have a material adverse effect on the demand for our products, with the potential to have a material adverse effect on our business, prospects, revenue, results of operation and financial condition.